Find Clinical Trials
Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets and micronized purified flavonoid fraction 500 mg tablets after 7 days of treatment followed by a follow-up period of 7 days in patients suffering from acute hemorroidal disease (HD)
Servier Protocol Code:
CL3-05682-108
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- venous disease
- MICRONISED PURIFIED FLAVONOID FRACTION
- S005682
Other study id numbers
Other identification numbers the study may be known by.
- CL3-05682-108